- PR Newswire•2 days ago
DUBLIN, April 28, 2017 /PRNewswire/ -- Allergan plc (AGN), a leading global biopharmaceutical company, today announced it has successfully completed the acquisition of ZELTIQ® Aesthetics, Inc., a medical technology company behind a proprietary controlled-cooling fat reducing treatment, CoolSculpting®. Allergan acquired ZELTIQ® Aesthetics for approximately $2.4 billion in cash. ZELTIQ® stockholders approved the transaction during its stockholder meeting held on April 27, 2017.
- Capital Cube•2 days ago
Categories: ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Allergan Plc. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average ... Read more (Read more...)
- TheStreet.com•4 days ago
Eyal Desheh became the Israel-based drugmaker's CFO in 2008.
AGN : Summary for Allergan plc Ordinary Shares - Yahoo Finance
Allergan plc (AGN)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||240.56 - 244.15|
|52 Week Range||184.50 - 261.27|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||6.39|
|Dividend & Yield||2.80 (1.17%)|
|1y Target Est||N/A|